» Articles » PMID: 37386137

Cancer Survivorship and Risk of Pregnancy Complications, Adverse Obstetric Outcomes, and Maternal Morbidities in Female Adolescents and Young Adults: a Nationwide Population-based Study from Taiwan

Overview
Journal Br J Cancer
Specialty Oncology
Date 2023 Jun 29
PMID 37386137
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Cancer treatment in female adolescent and young adult (AYA) cancer survivors (i.e., those diagnosed between 15 and 39 years of age) may adversely affect multiple bodily functions, including the reproductive system.

Methods: We initially assembled a retrospective, nationwide population-based cohort study by linking data from two nationwide Taiwanese data sets. We subsequently identified first pregnancies and singleton births to AYA cancer survivors (2004-2018) and select AYA without a previous cancer diagnosis matched to AYA cancer survivors for maternal age and infant birth year.

Results: The study cohort consisted of 5151 and 51,503 births to AYA cancer survivors and matched AYA without a previous cancer diagnosis, respectively. The odds for overall pregnancy complications (odds ratio [OR], 1.09; 95% confidence interval [CI], 1.01-1.18) and overall adverse obstetric outcomes (OR, 1.07; 95% CI, 1.01-1.13) were significantly increased in survivors compared with matched AYA without a previous cancer diagnosis. Specifically, cancer survivorship was associated with an increased risk of preterm labour, labour induction, and threatened abortion or threatened labour requiring hospitalisation.

Conclusions: AYA cancer survivors are at increased risk for pregnancy complications and adverse obstetric outcomes. Efforts to integrate individualised care into clinical guidelines for preconception and prenatal care should be thoroughly explored.

Citing Articles

Adverse Birth and Obstetric Outcomes in the Offspring of Male Adolescent and Young Adult Cancer Survivors: A Nationwide Population-Based Study.

Kao W, Chuang Y, Huang Y, Chen P, Liu Y, Wang C Cancer Epidemiol Biomarkers Prev. 2024; 34(2):324-331.

PMID: 39589389 PMC: 11799834. DOI: 10.1158/1055-9965.EPI-24-1122.

References
1.
Cheng C, Kao Y, Lin S, Lee C, Lai M . Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan. Pharmacoepidemiol Drug Saf. 2011; 20(3):236-42. DOI: 10.1002/pds.2087. View

2.
Barr R, Ferrari A, Ries L, Whelan J, Bleyer W . Cancer in Adolescents and Young Adults: A Narrative Review of the Current Status and a View of the Future. JAMA Pediatr. 2016; 170(5):495-501. DOI: 10.1001/jamapediatrics.2015.4689. View

3.
Desandes E, Stark D . Epidemiology of Adolescents and Young Adults with Cancer in Europe. Prog Tumor Res. 2016; 43:1-15. DOI: 10.1159/000447037. View

4.
van der Kooi A, Kelsey T, van den Heuvel-Eibrink M, Laven J, Wallace W, Anderson R . Perinatal complications in female survivors of cancer: a systematic review and meta-analysis. Eur J Cancer. 2019; 111:126-137. DOI: 10.1016/j.ejca.2019.01.104. View

5.
Chao C, Bhatia S, Xu L, Cannavale K, Wong F, Huang P . Chronic Comorbidities Among Survivors of Adolescent and Young Adult Cancer. J Clin Oncol. 2020; 38(27):3161-3174. PMC: 7499612. DOI: 10.1200/JCO.20.00722. View